Suppr超能文献

[呼吸道急性病毒感染合并细菌并发症患儿大肠微生物群落、免疫及干扰素状态的破坏及其通过大剂量强力双歧杆菌素的纠正]

[Disruption of microbiocenosis of the large intestine and the immune and interferon status in children with bacterial complications of acute viral infections of the respiratory tract and their correction by high doses of bifidumbacterin forte].

作者信息

Lykova E A, Vorob'ev A A, Bokovoĭ A G, Pobedinskaia I N, Gevondian V S, Gevondian N M, Mitrokhin S D, Minaev V I, Dzis N B, Makkaveeva L F, Kovalev I V, Murashova A O, Bondarenko V M

机构信息

Central Clinical Hospital, Medical Centre of Managing Department of the President of the Russian Federation, Moscow.

出版信息

Antibiot Khimioter. 2000;45(10):22-7.

Abstract

One hundred and twenty-nine children with acute viral and bacterial infection of the respiratory tract were examined and disturbance of the large intestine microflora was detected. It was characterized by significant reduction of lactobacilli, moderate growth of opportunistic bacteria and higher contents of Candida. Changes in T- and especially B-cellular immunity were observed in 35 per cent of the patients. In patients with decreased avidity of the immunoglobulins G in the peripheral blood the changes were observed in 82-100 per cent of the cases. In the majority of the patients the capacity for interferon genesis was suppressed. A shorten course (5 days) of the bifidumbacterin forte therapy in a dose of not less than 10(9) CFU/ml. normalized the intestinal microflora, improved the indices of the B- and T-cellular immunity (including the subpopulation of the T-helper cells but not the T-suppressor cells), stimulated NK and improved the ability to induce alfa- and gamma-interferons of the peripheral blood leukocytes. The experience with using high doses of bifidumbacterin forte was evident of its good tolerance and possible value in increasing the patient resistance to infection.

摘要

对129例急性呼吸道病毒和细菌感染患儿进行了检查,发现其大肠菌群紊乱。其特征为乳酸杆菌显著减少、机会性细菌适度生长以及念珠菌含量较高。35%的患者观察到T细胞尤其是B细胞免疫发生变化。外周血中免疫球蛋白G亲和力降低的患者,82% - 100%的病例出现了变化。大多数患者的干扰素生成能力受到抑制。采用不低于10(9) CFU/ml剂量的强力双歧杆菌素进行为期5天的短疗程治疗,可使肠道菌群正常化,改善B细胞和T细胞免疫指标(包括辅助性T细胞亚群,但不包括抑制性T细胞),刺激自然杀伤细胞并提高外周血白细胞诱导α和γ干扰素的能力。使用高剂量强力双歧杆菌素的经验表明其耐受性良好,且在增强患者抗感染能力方面可能具有价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验